Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
Treatment Study to assess of safety and efficiency of conditioning with Plerixafor and G-CSF
as additional agents for prevention of graft failure after transplantation in patients with
chronic granulomatous disease
Phase:
Phase 2
Details
Lead Sponsor:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology